Univercells

Univercells

Foundation date

23/01/2013

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Peptides
• #Therapeutics - Proteins
• #Therapeutics - Small molecules
• #Therapeutics - Vaccines
• #Other - Industrial Biotechnology
• #Pharma - Nucleic acid drugs

Therapeutic areas

• #Cardiovascular
• #Conditions originating in the perinatal period
• #Digestive system
• #Neoplasms / cancer / oncology
• #Respiratory system
• #Skin and subcutaneous tissue

Univercells is a global life science s company that makes biologics available to all. Leveraging our core strengths in scaling, production, and bioprocessing, we build businesses and find new ways to support access to medicines and promote sustainability. Through entrepreneurship and technology-driven affordability, we address the needs of the entire health value chain.Univercells is headquartered in Gosselies and benefits from the support of regional and national investors, as well as international investors, such as the Bill & Melinda Gates Foundation, EIB, Global Health Investment Fund, among others active in the health and vaccine industry.